×

Growth Reports

Growth Reports
Report Name

Fluid Biopsy Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Indication (Lung Cancer, Breast Cancer, Colorectal, Others), By Type (Circulating Tumor Cells, Circulating Tumor DNA, Cell-free DNA), Countries and Companies Report

Fluid Biopsy is projected to register a 14.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024714  |   No. of Pages: 205

Fibrotic Disease Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Medication, Organ Transplantation, Oxygen Therapy, Others), By Application (Idiopathic pulmonary fibrosis, Hepatic cirrhosis, Renal fibrosis, Cutaneous fibrosis, Others), By End-User (Hospitals, Academic and research institutes, Others), Countries and Companies Report

Fibrotic Disease Treatment is projected to register a 7.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024712  |   No. of Pages: 205

Fluorescent In Situ Hybridization Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Probe (Locus Specific Probes, Alphoid/Centromere Repeat Probes, Whole Chromosome Probes), By Application (Cancer Research, Genetic Diseases, Others), By End-User (Research Organizations, Clinical Organizations, Biotechnology Companies, Companion Diagnostics, Others), Countries and Companies Report

Fluorescent In Situ Hybridization is projected to register a 8.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024716  |   No. of Pages: 205

Fluidics for Preclinical Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Software and Accessories, Precision Syringe Pumps), By Application (Life Science Research, Clinical Application), Countries and Companies Report

Fluidics for Preclinical is projected to register a 18.7% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024715  |   No. of Pages: 205

Foot Drop Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Functional Electrical Stimulator, Braces, Splints), By Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders), Countries and Companies Report

Foot Drop Treatment is projected to register a 7.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024719  |   No. of Pages: 205

Fluoroscopy Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Device (Fixed Fluoroscopes, Mobile Fluoroscopes), By Application (Orthopedic, Cardiovascular, Pain Management, Neurology, Urology, General Surgery, Others), Countries and Companies Report

Fluoroscopy Devices is projected to register a 5.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024717  |   No. of Pages: 205

Foot Orthotic Insoles Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Material (Thermoplastic, Composite Carbon Fiber, Others), By Type (Pre-fabricated, Custom-made), By Distribution Channel (Drug Stores, Hospitals, Clinics, Others), Countries and Companies Report

Foot Orthotic Insoles is projected to register a 7.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024720  |   No. of Pages: 205

Focal Segmental Glomerulosclerosis Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disease (Primary FSGS, Secondary FSGS), By Treatment (Drug Therapy, Dialysis, Kidney Transplant), By Diagnosis (Kidney Biopsy, Creatinine Test, Others), Countries and Companies Report

Focal Segmental Glomerulosclerosis Treatment is projected to register a 6.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024718  |   No. of Pages: 205

Fully Automated Coagulometer Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Coagulation System, Consumables, Accessories), By End-User (Hospitals, Diagnostic Laboratories, Others), Countries and Companies Report

Fully Automated Coagulometer is projected to register a 7.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024723  |   No. of Pages: 205

Frontotemporal Disorders Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Cognitive Enhancers, Antipsychotics, Antidepressants, CNS Stimulants, Others), By Indication (Frontotemporal Dementia, Primary Progressive Aphasia, Movement Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Countries and Companies Report

Frontotemporal Disorders Treatment is projected to register a 6.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024722  |   No. of Pages: 205